Rohit Kulkarni, Roth MKM managing director, joins 'Squawk on the Street' to discuss how the ban of TikTok impacts the social ...

In a report released yesterday, Joseph Reagor from Roth MKM reiterated a Buy rating on Avino Silver & Gold (ASM – Research Report), with a ...

Fintel reports that on January 21, 2025, Roth MKM initiated coverage of Synergy CHC (NasdaqCM:SNYR) with a Buy recommendation. What is the Fund Sentiment? There are 2 funds or institutions reporting ...

Replimune Group Inc (REPL) stock saw a modest uptick, ending the day at $11.85 which represents a slight increase of $1.71 or 16.86% from the prior close of $10.14. The stock opened at $12.6 and ...

In a report released today, Darren Aftahi from Roth MKM maintained a Buy rating on TeraWulf Inc (WULF – Research Report), with a price target ...

LivePerson Inc (LPSN) stock saw a modest uptick, ending the day at $1.36 which represents a slight increase of $0.03 or 2.26% from the prior close of $1.33. The stock opened at $1.33 and touched a low ...

Roth MKM keeps a Buy rating on Imax (IMAX) with a $28 price target after the company signed an exclusive, worldwide deal with ...

Roth MKM lowered the firm’s price target on Mattel (MAT) to $20 from $21 and keeps a Neutral rating on the shares ahead of ...

Roth Mkm started coverage on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a report released on Friday,Benzinga reports. The brokerage issued a buy rating and a $7.00 price target on ...

Roth Mkm started coverage on shares of Verona Pharma (NASDAQ:VRNA – Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued a buy rating and a $68.00 price ...

Friday - Shares of Verona Pharma (NASDAQ:VRNA) received a positive outlook from Roth/MKM as the firm initiated coverage with a Buy rating and a 12-month price target of $68. The bullish stance is ...